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In 1982 the International Agency for Research
on Cancer (IARC) concluded there was sufﬁ-
cient evidence that benzene is carcinogenic to
humans, with evidence predominantly related
to associations between benzene and develop-
ment of acute non-lymphocytic leukemia
(IARC 1982). Subsequent epidemiologic
studies have supported that conclusion (Hayes
et al. 1997; Rinsky et al. 1987; Wong 1987;
Yin et al. 1996). In addition, molecular and
cytogenic studies provide evidence of induc-
tion of chromosomal alterations by benzene
that is likely to play a role in leukemogenesis
(Smith and Zhang 1998; Zhang et al. 2007).
Despite its status as a recognized leuke-
mogen, benzene exposure is common (IARC
1987). Benzene is an important raw material
for the chemical industry and an occasional
industrial solvent, as well as a component of
gasoline (Hricko 1994). Smokers commonly
experience protracted inhalation exposures to
benzene as a component of cigarette smoke
(Wallace et al. 1987). In addition, environ-
mental exposures to benzene arise from sources
such as gasoline vapor emissions and auto
exhaust (Wallace 1996). Consequently, the
identiﬁcation of a factor that inﬂuences a per-
son’s susceptibility to benzene-induced
leukemia has important public health implica-
tions, as does understanding the evolution over
time of leukemia rates after benzene exposure. 
Multistage theories of carcinogenesis pre-
dict that a person’s susceptibility to benzene-
induced leukemia will depend upon the age
at which exposure occurs, as the probability of
transition through the stage (or stages) of the
disease process unaffected by benzene exposure
are assumed to be age dependent (Thomas
1988). Moreover, age-related physiologic
changes might lead to changes in susceptibility
to benzene’s carcinogenic effects via changes in
benzene uptake and its metabolism (Kim et al.
2006). Despite its plausibility as an effect
measure modiﬁer, the epidemiologic literature
to date provides minimal information about
whether susceptibility to benzene-induced
leukemia varies with age at exposure. 
Multistage cancer models also predict that
effect of an increment of exposure on cancer
risk may vary with time since exposure.
Whereas some investigators have found that a
simple metric of cumulative exposure ade-
quately characterizes the exposure time–
response relationship (Crump 1994, 1996),
others have reported evidence of substantial
variation in the impact of benzene exposure on
leukemia risk with time since exposure
(Finkelstein 2000; Hayes et al. 1997; Silver
et al. 2002). 
The analyses reported in the present article
examine age at exposure and time since expo-
sure as modiﬁers of the association between the
leukemia mortality and occupational benzene
exposure in a cohort of rubber hydrochloride
workers. Previous analyses of these data have
been used by the U.S. Occupational Safety
and Health Administration (OSHA) to sup-
port the current permissible exposure limit for
benzene in the workplace and by the U.S.
Environmental Protection Agency (EPA) as
the basis for risk estimates for inhaled benzene
(OSHA 1987; U.S. EPA 1985). The objective
of these analyses was to use exposure time
windows and a multistage model to evaluate
temporal modiﬁers of the impact of benzene
on leukemia rates. 
Materials and Methods
This study is based upon the experience of
workers employed in the manufacture of a
natural rubber ﬁlm (rubber hydrochloride) at
two locations in Ohio. Natural rubber was
dissolved in benzene and spread over a con-
veyer; the benzene was evaporated and recov-
ered while the rubber ﬁlm was stripped from
the conveyor (Rinsky et al. 1987). Production
at the ﬁrst location commenced in 1939 and
ceased in 1976; production at the second
location began around 1937 and continued
until 1965. All nonsalaried workers employed
in a rubber hydrochloride department
between 1 January 1940 and 31 December
1965 were included in these analyses. 
Vital status was ascertained through
31 December 1996 via records of the Social
Security Administration, Ohio Bureau of
Motor Vehicles, and the National Death
Index. If there was no death indication for a
worker then they were assumed to be alive as
of 31 December 1996. Information was
obtained on underlying cause of death for
deceased workers, coded according to the revi-
sion of the International Classification of
Diseases (ICD) in effect at the time of death.
These analyses focus on leukemia {ICD-6 and
ICD-7 code 204 [World Health Organization
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BACKGROUND: Benzene is a human carcinogen. Exposure to benzene occurs in occupational and
environmental settings. 
OBJECTIVE: I evaluated variation in benzene-related leukemia with age at exposure and time since
exposure. 
METHODS: I evaluated data from a cohort of 1,845 rubber hydrochloride workers. Benzene
exposure–leukemia mortality trends were estimated by applying proportional hazards regression
methods. Temporal variation in the impact of benzene on leukemia rates was assessed via exposure
time windows and ﬁtting of a multistage cancer model. 
RESULTS: The association between leukemia mortality and benzene exposures was of greatest mag-
nitude in the 10 years immediately after exposure [relative rate (RR) at 10 ppm-years = 1.19; 95%
conﬁdence interval (CI), 1.10–1.29]; the association was of smaller magnitude in the period 10 to
< 20 years after exposure (RR at 10 ppm-years = 1.05; 95% CI, 0.97–1.13); and there was no evi-
dence of association ≥ 20 years after exposure. Leukemia was more strongly associated with benzene
exposures accrued at ≥ 45 years of age (RR at 10 ppm-years = 1.11; 95% CI, 1.04–1.17) than with
exposures accrued at younger ages (RR at 10 ppm-years = 1.01; 95% CI, 0.92–1.09). Jointly, these
temporal effects can be efficiently modeled as a multistage process in which benzene exposure
affects the penultimate stage in disease induction.
CONCLUSIONS: Further attention should be given to evaluating the susceptibility of older workers to
benzene-induced leukemia.
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The exposure of interest was defined as
cumulative benzene exposure, expressed in
parts per million-year (ppm-year). Annual
exposure rate estimates by plant, department,
and job were developed by Rinsky et al. (2002,
1987) based on available air sampling data.
Utterbach and Rinsky (1995) have reviewed
the methods employed in this assessment of
benzene exposure among rubber hydrochloride
workers. The U.S. National Institute for
Occupational Safety and Health provided a ﬁle
that contained a plant, department, and job
code, and start and ﬁnish dates, for each job
held by each worker. Using this information,
benzene exposure histories were computed for
each worker as the product of the length of
employment in each job in a year by the esti-
mated benzene exposure rate for that job. 
Statistical methods. Cox proportional haz-
ards regression models were fitted to these
data via the statistical program PECAN, with
attained age as the primary time scale
(Preston et al. 1993). Model covariates
included a categorical indicator of birth
cohort (classified as born before 1905, 1905
to < 1910, 1910 to < 1915, 1915 to < 1920,
or after 1920), a binary indicator of sex, and a
binary indicator of employment status (active
employment status began when a person
started employment and ended 1 week after
the end of employment in order to allow for
inaccuracies in personnel records regarding
the day last employed) (Arrighi and Hertz-
Picciotto 1994; Steenland and Stayner 1991;
Steenland et al. 1996). The majority (99%) of
workers of known race in this cohort was
white, and no deaths due to leukemia were
observed among nonwhite workers; therefore,
race was not included as a covariate in these
analyses. In analyses of cumulative exposure
(expressed in 10-ppm-year increments) log-
linear regression models were ﬁtted, providing
an estimate of the log relative rate per
10 ppm-years; we report the anti-log of this
estimate and discuss it as an estimate of the rel-
ative rate at 10 ppm-years. Ninety-ﬁve percent
conﬁdence intervals (CIs) were estimated via
the likelihood method.
Cumulative exposure was treated as a time-
varying explanatory variable that described the
benzene exposures accrued prior to a person’s
entry into a risk set in the Cox regression
analysis. The model with a single parameter for
cumulative benzene exposure implies that the
magnitude of the hazard ratio does not depend
on when exposures occurred. Exposure time
window analyses were conducted to assess
whether the relationship between disease risk
and benzene exposure depends on when expo-
sures occurred (Checkoway et al. 1990;
Richardson and Ashmore 2005; Thomas
1988). A model with three exposure time win-
dows, deﬁned a priori, described the associa-
tion between leukemia rates and exposures
accrued in the periods < 10 years, 10 to
< 20 years, and ≥ 20 years prior to a person’s
entry into a risk set in the regression analysis
(Rothman 1981). To assess variation in expo-
sure effects with age at exposure, metrics of
cumulative exposures accrued at < 45 and
≥ 45 years of age were examined (Richardson
and Wing 1998). Each model was compared
with a standard model of lifetime cumulative
exposure by means of a likelihood ratio test
(LRT); the difference between model deviances,
described as an LRT statistic, can be inter-
preted using a chi-square distribution with
degrees of freedom (df) equal to the difference
in the numbers of model parameters. 
Multistage models of carcinogenesis, of
which the best known is the Armitage–Doll
model, involve the mathematic expression of
hypotheses about the process of carcinogenesis
(Armitage and Doll 1954). Central to the
Armitage–Doll model is the concept that can-
cer arises as the result of a single cell undergo-
ing a series of transformations. The model
predicts that cancer incidence, I, will increase
as an integer power of attained age, a, with the
integer, depending on the number of stages, k,
required for cancer induction. Speciﬁcally, the
model posits the relationship I=  c a k–1, where c
is a constant that is proportional to the product
of the transition rates. When considering the
effect of an environmental carcinogen, the
transition rate from one rate-limiting step to
the next is often assumed to be affected in a
linear fashion by exposure. If exposure inﬂu-
ences the transition rate for a single stage, j < k,
this implies a linear relative rate model of the
form RR (relative rate) = 1 + δj,kZ, where Z is a
weighted cumulative exposure metric calcu-
lated for each person (Thomas 1988;
Whittemore 1977). Specifically, if a denotes
the attained age of members of a risk set enu-
merated for a Cox regression analysis, and a0 is
the age at which an increment of exposure
occurs, then the weight assigned to that expo-
sure increment is given by the expression,
w(a0)=  ( 1÷ ak–1) a0
j–1 (a–a0)k–j–1. The
weighted cumulative exposure metric Z repre-
sents the sum of weighted exposure increments
accrued through age a. 
Leukemia incidence rates increase approxi-
mately as a function of age to the fourth
power, suggesting a process of carcinogenesis
that involves ﬁve stages (Little et al. 1992; Ries
et al. 2003). Therefore, a disease process that
involves five stages was posited (i.e., k = 5)
and weighted cumulative exposure metrics for
each integer value of j<kwere calculated.
Relationships between leukemia mortality and
these weighted cumulative exposure metrics
were evaluated, and fitted regression models
were compared with reference to residual
model deviance (–2 log likelihood). Alternative
models with fewer than ﬁve stages and those
with more than ﬁve stages were also evaluated.
Regression analyses were conducted via the
log-linear rate model as well as via the linear
relative rate model. 
Results
Table 1 shows the distribution of major charac-
teristics among cases and noncases in the study
cohort. A single leukemia death was observed
among the females in the study cohort. Over
one-third of the leukemia cases were ascertained
among workers born before 1905, whereas
nearly 60% of the noncases were born in the
period 1920 or later. Leukemia cases were
employed for a longer average duration than
noncases, tended to start employment at older
ages than noncases, and accrued higher average
cumulative benzene exposures (144 ppm-years)
than noncases (34 ppm-years). Two percent of
the workers were hired before 1940, 19% were
hired in the period 1940–1944, and the
remainder were hired in 1945–1975.
Table 2 reports estimated RRs for cate-
gories of benzene exposure. The rate ratio for
Benzene and leukemia mortality
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Table 1. Characteristics [n (%)] of cohort of 1,845 rubber hydrochloride workers stratiﬁed by leukemia case
status, Ohio, 1940–1996.
Cases Noncases 
Characteristic (N = 17) (N = 1,828)
Sex
Male 16 (94) 1,705 (93)
Female 1 (6) 123 (7)
Birth cohort
< 1905 6 (35) 230 (13)
1905 – <1910 2 (12) 131 (7)
1910 – <1915 3 (18) 193 (11)
1915 – <1920 3 (18) 226 (12)
< 1920 3 (18) 1,048 (57)
Employment status
Employed 2 (12) 10 (1)
Terminated 15 (88) 1,818 (99)
Age at entry (years, mean ± SD) 41 ± 11 32 ± 11
Age at exit (years, mean ± SD) 62 ± 17 67 ± 12
Duration of employment (years, mean ± SD) 7 ± 8 4 ± 7
Cumulative exposure (ppm-years, mean ± SD) 144 ± 207 34 ± 91the contrast drawn between the categories 1 to
< 50 ppm-years and < 1 ppm-year was below
unity (Table 2). When considering contrasts
drawn between 50 to < 250, 250 to < 500, and
≥ 500 ppm-years and < 1 ppm-year, the rate
ratios were greater than unity and increased in
magnitude with increasing cumulative expo-
sure level, although the associated 95% CIs
were relatively wide for each exposure category,
reﬂecting the small numbers of leukemia cases
observed within each category. 
There was a positive trend in the leukemia
mortality rate with cumulative benzene expo-
sure (Table 3). Table 3 also describes the asso-
ciation between leukemia and cumulative
benzene exposure accrued in the periods
< 10 years, 10 to < 20 years, and ≥ 20 years
prior. The largest magnitude of association
was observed for benzene exposures accrued
in the period < 10 years prior, whereas expo-
sures received 10 to < 20 years previously
exhibited a smaller, positive association with
leukemia, and benzene exposures received
≥ 20 years prior showed no association with
leukemia. A model with three exposure time
windows provided a substantially better ﬁt to
these data than a lifetime cumulative exposure
model (LRT = 13.2, 2 df, p-value = 0.001).
Table 4 reports the association between
cumulative benzene exposures accrued at
younger (< 45 years) and older (≥ 45 years)
ages and leukemia in the periods < 10 years, 10
to < 20 years, and ≥ 20 years after exposure.
When considering benzene exposures accrued
at ≥ 45 years of age, there was a positive associ-
ation with leukemia mortality in the period
shortly after exposure (< 10 years after expo-
sure); there was minimal evidence of associa-
tion within the period ≥ 10 years after
exposure. Benzene exposures accrued at
younger ages exhibited little evidence of associ-
ation with leukemia. The ﬁt of this model with
exposure time windows deﬁned jointly by age
at exposure and time since exposure was sub-
stantially better than the ﬁt of a model for life-
time cumulative exposure (LRT = 16.9, 5 df,
p-value = 0.005). Table 4 also reports estimates
of the association between cumulative benzene
exposures accrued at younger (< 45 years) and
older (≥ 45 years) ages and leukemia, summa-
rized over all periods of time since exposure. A
model that included separate terms for two
age-at-exposure time windows provided a
slightly better ﬁt to these data than the simpler,
nested model that included a single parameter
for cumulative benzene exposure accrued at all
ages (LRT = 3.3, 1 df, p-value = 0.071). 
The results reported in Tables 3 and 4 are
minimally impacted by inclusion of birth
cohort, sex, or employment status as covari-
ates; none of the parameter estimates on
which the reported effect measures were based
changed by > 10% on exclusion of these
covariates. The linear relative rate model pro-
vided an equivalent ﬁt to these data for analy-
ses of lifetime cumulative exposure; however,
the log-linear model ﬁtted these data better for
the exposure time window analyses. The cut
point defining younger versus older age at
exposure was chosen to broadly partition the
ages at which exposures occur; there was mini-
mal impact on relative rate estimates of select-
ing alternative cut points of 40 years or
50 years (results not shown).
In contrast to the exposure time window
analyses presented above, which impose a
piecewise constant model to describe temporal
variation in exposure effects, the Armitage–
Doll model implies a smooth time-varying
exposure weighting function that jointly
describes age at exposure and latency effects.
Residual model deviances were compared for
models in which benzene exposure acted upon
the ﬁrst, second, third, or fourth stage of a ﬁve-
stage disease process (Table 5). A model under
which the transition rate for the fourth stage
was affected by benzene exposure resulted in
the lowest residual deviance and therefore pro-
vided the best ﬁt to these data. Figure 1A illus-
trates how the estimated effect of benzene
exposure varies with time since exposure;
the figure illustrates the natural log of the
estimated relative rate of leukemia per
10 ppm-years for those 65 years of age (i.e.,
typical of the ages at which leukemia deaths
occurred in this population). Consistent with
observations from our exposure time window
analyses, the modeled effect was largest for
exposures that occurred in the prior decade
and diminished rapidly with time since expo-
sure. Figure 1B illustrates how the estimated
effect of benzene exposure varies with age at
exposure. As observed via time window analy-
ses, the exposure effect was much smaller for
exposures accrued prior to 45 years of age; the
estimated effect of benzene exposure increased
with age at exposure > 45 years of age.
Multistage models were also ﬁtted using a lin-
ear relative rate model; a model in which the
transition rate for the penultimate stage was
affected by benzene exposure provided the best
ﬁt to these data (Table 5). Evaluation of alter-
native models with as few as three stages, or as
many as 15 stages, led to similar conclusions
(see Supplemental Material online at http://
www.ehponline.org/docs/2008/10841/suppl.
pdf); in all such models the best-ﬁtting model
is one in which benzene exposure acts at the
penultimate stage. 
Discussion
In the United States, the OSHA standard for
benzene exposure is 1 ppm. The analyses in
the present article suggest that accrual of ben-
zene exposure at that level for a decade
implies a modest increase in the relative rate
of leukemia mortality, with the magnitude of
the excess relative rate diminishing with time
since exposure (Table 3). Because leukemia is
a rare disease, this means that if a person is
exposed to 1 ppm of benzene for a decade, it
is still unlikely that they will develop
leukemia. To understand the impact of ben-
zene exposure on leukemia risk at a popula-
tion level, however, the magnitude of the
dose–response association and its variation
over time must be accurately characterized. In
this study population, the effect of benzene
exposure on leukemia did not appear to per-
sist indefinitely, but rather diminished with
time since exposure. Of course, caution is
warranted in drawing conclusions from an
historical cohort study of a population in
which working conditions differed substan-
tially from those typical of contemporary work
settings in the United States. Nonetheless, the
ﬁndings of this historical cohort of U.S. work-
ers may have substantial relevance for contem-
porary workers, both in the United States
and abroad. 
In prior analyses of this cohort, Crump
(1994, 1996) investigated the hypothesis that
the effect of benzene on leukemia risk dimin-
ishes with time since exposure by applying a
set of time-dependent exposure weights with
values informed a priori by latency patterns
for leukemia after radiotherapy for ankylosing
spondylitis. Crump reported that analyses
using a simple metric of cumulative exposure
fitted these data better than analyses using
those exposure weights (Crump 1996). In the
present paper, rather than assigning a set of
Richardson
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Table 2. Estimated association between cumulative exposure to benzene and leukemia mortality among
rubber hydrochloride workers, Ohio, 1940–1996. 
Cumulative exposure to benzene (ppm-years)
< 1 1 to < 50 50 to < 250 250–500 ≥ 500
RR (95% CI) 1 0.8 (0.2–3.2) 2.5 (0.6–10.2) 10.5 (2.3–46.6) 13.9 (0.7–116.1)
Deaths (no.) 5 3 4 4 1
Table 3. Estimated relative rates (and associated
95% CIs) for leukemia mortality expressed as a trend
with benzene exposure (10 ppm-years) and within
time windows deﬁned by time since exposure. 
RR at 10 ppm-years (95% CI)
Cumulative exposure 1.05 (1.02–1.08)
Time since exposure
< 10 years prior 1.19 (1.10–1.29)
10 to < 20 years prior 1.05 (0.97–1.13)
≥ 20 years prior 1.00 (0.90–1.05)
Test of heterogeneity
LRT, 2 dfa 13.1
p-Value 0.001
aLRT comparing a model with terms for three exposure
time windows to a model with one term for lifetime cumu-
lative exposure.exposure weights based on patterns observed
in a study of radiation exposure effects, the
method of exposure time–window analysis
was used. The overall association between
cumulative exposure and leukemia mortality
(RR at 10 ppm-years = 1.05) is nearly identi-
cal to the estimate derived by Rinsky et al.
(2002) via a log-linear Cox regression model;
the evidence of heterogeneity of benzene expo-
sure effects with time since exposure is consis-
tent with previous observations reported by
Silver et al. (2002) and Finkelstein (2000). 
These findings suggest that the effect of
benzene on leukemia mortality is jointly char-
acterized as an effect of age at exposure and
time since exposure. The temporal pattern is
consistent with a multistage cancer model
with benzene affecting a late stage in the
induction of leukemia; the relative rate of
leukemia per unit exposure increases with age
at exposure and decreases with time since
exposure (Thomas 1988). This conclusion is
supported by analyses that involve fitting
weighting expressions implied by the
Armitage–Doll model. These weighted expo-
sure metrics were evaluated via fittings of
standard log-linear models as well as via fit-
tings of linear relative rate models [the latter
being the model form implied by the work of
Whittemore (1977), whereas the former
approach was consistent with the model form
used in the exposure time–window analyses].
In these analyses a model with ﬁve stages was
posited. Armitage and Doll intentionally used
the word “stage” rather than mutation to
allow for the possibility of nonmutational
events leading to cancer induction (Doll
2004). They correctly maintained that the
application of multistage models for cancer
risk estimation offers a heuristic tool that
allows an investigator to explore potentially
complex dose-time–response patterns by
imposing some relatively minor constraints
based on biological expectations about the
disease process. Although mutational events
are clearly central to carcinogenesis, useful
insights from these models may be obtained
even if carcinogenesis is viewed more gener-
ally as resulting from a series of rate-limiting
pathogenic events, with exposure inﬂuencing
one or more transition rates (Hanahan and
Weinberg 2000; Morrison 1979). 
The validity of these ﬁndings depends, in
part, on the validity of the benzene exposure
estimates derived for this cohort. To the extent
that the exposure measurement error conforms
to a classical model, attenuation of the dose
response would be expected. However, non-
random measurement errors could lead to bias
away from the null. Estimates of these histori-
cal benzene exposures used air monitoring
results, which were relatively sparse for the
early years of operation (Utterback and Rinsky
1995; Williams and Paustenbach 2003). In
theory, temporal variation in the magnitude of
a benzene–leukemia association (e.g., dimin-
ished evidence of association with increasing
time since exposure) could reflect increasing
exposure misclassiﬁcation for benzene exposure
estimates for periods of employment further in
the past. While it is difﬁcult to assess such con-
cerns, the observation in this cohort that the
benzene–leukemia association diminished with
time since exposure is consistent with patterns
observed in other populations of benzene-
exposed workers (Glass et al. 2004; Hayes et al.
1996), suggesting that the temporal patterns in
this cohort are not simply an artifact of errors
in exposure estimates.
Although the ﬁtted models include a rela-
tively small number of covariates, concerns
about bias because of residual confounding
are tempered by the fact that there are few
leukemogens that are plausible strong con-
founders of the association under study.
Cigarette smoking is a nonoccupational
source of benzene exposure and could, in the-
ory, confound our estimates of association
between occupational benzene exposure and
leukemia. However, given the relatively small
magnitude of association between smoking
and leukemia mortality, high levels of correla-
tion between occupational benzene exposure
and smoking would be necessary to account
for even modest dose–response trends for
leukemia (Axelson and Steenland 1988;
Siemiatycki et al. 1988). 
The analyses in this article examined the
broad category of all leukemia deaths. It is rea-
sonable to posit that associations may vary in
magnitude and temporal pattern by disease
subtype. Although evaluation of heterogeneity
in exposure–response analyses for different
subtypes of leukemia is of interest because of
small numbers of leukemia cases and the
sparse information available from the death
certificates, subtype-specific exposure–
response analyses were not conducted. In
addition, the use of mortality data in these
analyses does not allow assessment of whether
benzene exposure inﬂuences disease prognosis
or incidence; therefore, it is possible that ben-
zene exposures accrued proximate to death
could influence mortality rates by reducing
survival time rather than by increasing inci-
dence rates. The relatively small number of
Benzene and leukemia mortality
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Figure 1. (A) Fitted time-varying exposure weighting function. Log relative rate (RR) of leukemia per 10
ppm-year benzene exposure by time since exposure for a person 65 years of age, rubber hydrochloride
workers, Ohio, 1940–1996. (B). Fitted time-varying exposure weighting function. Log relative rate (RR) of
leukemia per 10 ppm-year benzene exposure by age at exposure for a person 65 years of age, rubber
hydrochloride workers, Ohio, 1940–1996.
0.16
0.14
0.12
0.10
0.08
0.06
0.04
0.02
0.00
0 5 10 15 20 25 30 35 40 45 50
Time since exposure (years) Age at exposure (years)
I
n
 
(
R
R
 
a
t
 
1
0
 
p
p
m
-
y
e
a
r
s
)
15 20 25 30 35 40 45 50 55 60 65
0.16
0.14
0.12
0.10
0.08
0.06
0.04
0.02
0.00
I
n
 
(
R
R
 
a
t
 
1
0
 
p
p
m
-
y
e
a
r
s
) A B
Table 4. Estimated association between leukemia mortality and cumulative exposure to benzene in exposure
time windows cross-classiﬁed by age at exposure and time since exposure. 
RR at 10 ppm-years (95% CI)
Accrued at < 45 years of age Accrued at ≥ 45 years of age
Cumulative exposure 1.01 (0.92–1.09) 1.11 (1.04–1.17)
Time since exposure
< 10 years prior 0.78 (ND–1.23) 1.22 (1.11–1.32)
10 to < 20 years prior 1.05 (0.89–1.22) 1.03 (0.92–1.13)
≥ 20 years prior 1.01 (0.90–1.09) 0.93 (0.55–1.10)
ND, not determined (the 95% conﬁdence bound was not determined via the likelihood method). LRT comparing model with
six exposure time windows to the cumulative exposure model = 16.9, 5 df, p-value = 0.005.
Table 5. Residual deviances from ﬁtting of log-linear and linear RR regression models. 
Stage affected by benzene (j) Log-linear rate model Linear RR model
1 211.23 209.5
2 209.76 206.9
3 204.74 203.4
4 193.60 200.1
Comparison of models in which a cumulative weighted benzene exposure metric was derived via a multistage model with
ﬁve stages (i.e., k = 5), assuming a single stage, j, was affected by benzene exposure.Richardson
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leukemia deaths also suggests that model
results are relatively sensitive to small changes
in distribution of events; adding or subtracting
a single case in the highest exposure category
could lead to a substantial change in the esti-
mates of the association between cumulative
exposure and leukemia mortality. Last, the
Armitage–Doll model, while often illustrated
using mortality data (Armitage and Doll
1954), is posited as a model of disease inci-
dence; it is likely that the conclusions obtained
in these analyses would differ from those
obtained via analyses of incidence data.
Since 1987, the Chinese Academy of
Preventive Medicine has collaborated with the
U.S. National Cancer Institute on a large-scale
study of cancer among Chinese workers
exposed to benzene (NCI-CAPM study)
(Hayes et al. 1997). Although the NCI-CAPM
study encompasses more leukemia cases than
in this rubber hydrochloride cohort study,
several concerns have been raised about
the validity of the exposure estimates used in
the previously reported analyses of the
NCI-CAPM study (Hayes et al. 2001).
Therefore, the rubber hydrochloride cohort
examined in this article remains one of the
important epidemiologic resources for ben-
zene risk assessment.
The findings illustrate the importance of
attention to dynamic changes in exposure–
response patterns with temporal factors such
as time since exposure and age at exposure.
Failure to account for variation with time
since exposure in the effect of an increment of
benzene exposure on the relative rate of
leukemia may lead to underestimation of the
excess rate of leukemia in some risk periods
(and overestimation of the excess rate of
leukemia in other risk periods). In these analy-
ses, the effect of an increment of benzene
exposure on leukemia mortality appears
promptly, diminishes with time since expo-
sure, and is of greater magnitude for workers
exposed at older ages than for those exposed at
younger ages. These temporal patterns of asso-
ciation are consistent with a late-stage carcino-
gen and suggest that occupational protection
efforts give particular consideration to the risks
of benzene-induced leukemia faced by older
workers. Further attention should be given to
assessment of age at exposure in other benzene-
exposed populations, speciﬁcally to the poten-
tially greater susceptibility of older workers to
benzene-induced leukemia. 
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